ARTICLE | Financial News
Erasca extends series A by $22M
March 8, 2019 7:23 PM UTC
Erasca raised additional funds to enable compound in-licensing and accelerate development of its Oncology Pattern Recognition Algorithm (OPRA) for discovering cancer cures.
Erasca Inc. (San Diego, Calif.) raised $22 million in a series A extension, bringing the round's total to $64 million. The extension included new investors Arch Venture Partners, Andreessen Horowitz and Reneo Capital, plus undisclosed investors...
BCIQ Company Profiles